The proteinase k market is expected to reach approximately USD 30.2 million in 2025 and expand to around USD 48.2 million by 2035, reflecting a compound annual growth rate (CAGR) of 4.8% over the ...

The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years. Advancements in genetic ...

Plastic milk jugs are a ubiquitous part of the American supermarket landscape, but one feature of these containers has ...

The veterinary vaccines market is estimated to reach USD 9,433.9 million in 2024. It is estimated that revenue will increase ...

New studies stemming from the Armamentarium consortium outline findings that advance tools based on Adeno-associated virus ...

A new “DNA atlas” of Ireland is revealing some of the surprising ways historic kingdoms have influenced populations on the island—and it offers the first genetic evidence that Vikings ...

The food enzyme market is witnessing strong growth driven by increasing demand for processed foods and advancements in food processing technologies. Rising demand for clean-label and functional foods ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that a new indication application (the "Application") for the Company's trophoblast cell-surface antigen 2 (TROP2)-directed ...

Although most notable organizations and research suggest that GMO foods are safe and sustainable, some people claim they may harm your health and the environment. GMOs, short for genetically ...

This study identifies 53BP1 as an interaction partner of GMCL1 (a likely CUL3 substrate receptor). The study seeks to link this finding to regulation of the mitotic surveillance pathway and paclitaxel ...

Annual Meeting is scheduled to take place in Chicago, Illinois, USA from May 30 to June 3. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK, the "Company") will present results from ...

The liposarcoma pipeline report provides detailed profiles of pipeline assets, a comparative analysis of clinical and non-clinical stage liposarcoma drugs, inactive and dormant assets, a comprehensive ...